By lowering the NT‐proBNP age‐adjusted thresholds by 25%, 30% and 40% in obesity category I, II and III, respectively, the sensitivity and specificity was comparable with the test performance seen in the cohort overall. The gene discussed is NPPB; the disease is obesity disorder.